David Hollander

Dr. Hollander currently serves as Chief Research & Development Officer of Aerie Pharmaceuticals where he is responsible for overseeing clinical, preclinical, and development groups, as well as medical and professional affairs. Previously he served as the Chief Medical Officer, and Senior Vice President at Ora, Inc, an ophthalmic-specific contract research organization.

Prior to this, he spent a decade at Allergan with increasing leadership roles, including Head of EyeCare for Global Medical Affairs, as well as VP and Therapeutic Area Head of Anterior Segment Clinical Development.